Antimicrobial Peptides: A Roadmap for Accelerating Discovery and Development | Agenda Bookshop Skip to content
Please note that books with a 10-20 working days delivery time may not arrive before Christmas.
Please note that books with a 10-20 working days delivery time may not arrive before Christmas.
Age Group_Uncategorized
Age Group_Uncategorized
automatic-update
B01=Gregory R. Wiedman
B01=Juan C. Cruz
B01=Luis H. Reyes
Category1=Non-Fiction
Category=MMG
Category=PNN
Category=PSB
COP=United States
Delivery_Pre-order
Language_English
PA=Not yet available
Price_€100 and above
PS=Forthcoming
softlaunch

Antimicrobial Peptides: A Roadmap for Accelerating Discovery and Development

English

Antimicrobial Peptides: A Roadmap for Accelerating Discovery and Development covers the most important efforts of scientists and engineers worldwide to accelerate the process of discovery, production, and eventual market penetration of more potent antimicrobial peptides. These efforts have been fueled by emerging technologies such as artificial intelligence and data science, molecular and CFD simulations, easy-to-use process simulation packages, microfluidics, 3D-printing, among many others. Such technologies can now be implemented and scaled up quickly and at relatively low cost in low-budget production facilities, critical to moving to sustainable and marketable products worldwide. Discovering novel antimicrobial peptides rationally and cost-effectively has emerged as one of the significant challenges of modern biotechnology. Thus far, this process has been tedious and costly, resulting in molecules with activities far below those needed to address the current challenge of microbial resistance to antibiotics that takes the lives of thousands of people around the world every year. Finally, the book also highlights how multidisciplinary teams have assembled to address the challenges of manufacturing, biological testing, and clinical trials to finally reach complete translation. See more
Current price €160.54
Original price €168.99
Save 5%
Age Group_Uncategorizedautomatic-updateB01=Gregory R. WiedmanB01=Juan C. CruzB01=Luis H. ReyesCategory1=Non-FictionCategory=MMGCategory=PNNCategory=PSBCOP=United StatesDelivery_Pre-orderLanguage_EnglishPA=Not yet availablePrice_€100 and abovePS=Forthcomingsoftlaunch

Will deliver when available. Publication date 01 Dec 2024

Product Details
  • Weight: 450g
  • Dimensions: 152 x 229mm
  • Publication Date: 01 Dec 2024
  • Publisher: Elsevier - Health Sciences Division
  • Publication City/Country: United States
  • Language: English
  • ISBN13: 9780443153938

About

Luis H. Reyes is an Associate Professor at Universidad de Los Andes (Bogotá Colombia) and Director of the Product and Process Design Group. Luis is a chemical engineer (Universidad Industrial de Santander Colombia) with a PhD. in Chemical Engineering from Texas A&M University (College Station TX USA). His research interest focuses on applying biological engineering to design and develop bioprocesses and bioproducts using various tools borrowed from the natural sciences such as molecular and synthetic biology reverse engineering of microorganisms laboratory adaptive evolution and microbiology. He teams with an interdisciplinary research group in the biomedical engineering area to develop bionanoconjugated vehicles to transport and deliver biological molecules with therapeutic potential including gene and enzyme replacement therapies. He also works in the discovery and production of peptides with applications in the medical food and petrochemical industries. In food engineering Luis studies the sensory design of beer and the protein replacement of dairy products. Juan Carlos Cruz obtained his undergraduate degree in Chemical Engineering from the National University of Colombia (2002) and later his Ph.D. in Chemical Engineering from Kansas State University (KSU) (2010) for his work on a new platform for enzyme immobilization to address biocatalysis challenges in non-aqueous media. Cruz has experience as Head of New Product Development in a chemical company where he developed several nanotechnological applications to improve critical attributes of plastics according to the requirements and standards of new market niches. In 2016 he joined the Department of Biomedical Engineering at Universidad de Los Andes (Bogotá Colombia). Cruz has more than fifteen years of working in the fields of industrial and medical biotechnology and in particular in the development of nanobiocatalysts the fundamental understanding of protein-protein protein-surface and protein-lipid interactions the development of new nanoparticulate vehicles for the release and guidance of pharmacological molecules and the search for unique peptides with membrane activity. Gregory R. Wiedman works at Seton Hall University in NJ USA.

Customer Reviews

Be the first to write a review
0%
(0)
0%
(0)
0%
(0)
0%
(0)
0%
(0)
We use cookies to ensure that we give you the best experience on our website. If you continue we'll assume that you are understand this. Learn more
Accept